"Between too much information and evolving regulations, data deluge is an ongoing challenge. This is why we apply the five Vs of data: variety, volume, value, velocity, and veracity."
EPM held a Q&A session with Vincent Rolland, associate director, expert lead data management programmer, biometry, Idorsia Pharmaceuticals, and Richard Young, vice president, Vault CDMS Strategy, Veeva, to discuss how investing in digital data management can benefit biopharma, from clinical trials through to market.
Q. What are the major considerations for biopharma companies wanting to invest in digital data management?